Tilray Executive and Leadership Team

Irwin Simon, the Chairman & Chief Executive Officer at Tilray, directs the overarching corporate strategy and long-term vision for the organization. Overseeing the integration of medical cannabis research with large-scale production, the Chairman & Chief Executive Officer ensures alignment across all international business units. This leadership role involves managing complex stakeholder relationships and driving expansion into emerging global markets. By prioritizing operational excellence and pharmaceutical-grade quality, Irwin Simon directly impacts the company's competitive position within the global cannabinoid sector. Ultimately, Simon secures the financial health and market influence of the enterprise through disciplined capital allocation and strategic partnerships that solidify the brand as a leader in the pharmaceutical manufacturing space, consistently delivering value to shareholders while maintaining strict regulatory compliance across all operational territories.

Carl Merton, the Chief Financial Officer at Tilray, manages the fiscal health and capital structure of the organization. Overseeing financial reporting, budgeting, and investor relations, the Chief Financial Officer ensures transparency and accuracy in all monetary disclosures. This leadership role involves analyzing market trends to optimize resource allocation for cannabis cultivation and distribution projects. By implementing robust financial controls, Carl Merton directly impacts the company's ability to scale operations efficiently across North American and international markets. Ultimately, Merton supports sustainable growth by mitigating fiscal risks and providing the strategic insights necessary for the Board to make informed investment decisions regarding new pharmaceutical product development and infrastructure upgrades, ensuring the long-term viability of the business model in a rapidly evolving regulatory environment.

Blair MacNeil, the President, Canada at Tilray, directs all commercial activities and market development initiatives within the domestic Canadian landscape. Overseeing the cultivation, production, and distribution of medical cannabis products, the President, Canada ensures that local operations meet the specific needs of the Canadian healthcare system and consumer base. This leadership role involves navigating complex provincial regulations and managing relationships with key healthcare providers and retail partners. By optimizing the local supply chain and product portfolio, Blair MacNeil directly impacts the company's market share and brand reputation within the region. Ultimately, MacNeil drives revenue growth and operational excellence by tailoring the company's global pharmaceutical expertise to the unique requirements of the Canadian market, ensuring consistent product availability and high standards of patient care.

Lloyd Brathwaite, the Chief Information Officer at Tilray, architects the digital infrastructure and data security frameworks supporting the company's pharmaceutical manufacturing operations. Overseeing the implementation of advanced analytics and supply chain management software, the Chief Information Officer ensures seamless connectivity between research facilities and distribution centers. This leadership role involves protecting sensitive intellectual property and patient data through rigorous cybersecurity protocols. By modernizing internal systems, Lloyd Brathwaite directly impacts the efficiency of production cycles and the accuracy of inventory tracking across global operations. Ultimately, Brathwaite drives digital transformation initiatives that enable the organization to maintain a competitive edge in the medical cannabis industry, fostering a technology-driven culture that prioritizes data-backed decision-making and operational agility in every aspect of the business.

Roger Savell, the Chief Administrative Officer at Tilray, manages the internal organizational processes and corporate governance frameworks that support the company's daily operations. Overseeing human resources, legal compliance, and facility management, the Chief Administrative Officer ensures that all departments adhere to the stringent regulatory standards required for pharmaceutical manufacturing. This leadership role involves streamlining administrative workflows to enhance productivity and cross-departmental collaboration. By fostering a culture of compliance and operational efficiency, Roger Savell directly impacts the company's ability to maintain high-quality production standards across all regional sites. Ultimately, Savell provides the structural foundation necessary for the organization to scale effectively, ensuring that internal policies and administrative support systems remain aligned with the broader strategic goals of the business in the competitive medical cannabis market.